SCHEMBL12058491

SCHEMBL12058491

Cc1cc2cc(-c3c(Cl)nc(NCC(F)(F)F)nc3N[C@@H]3C[C@H](CO)[C@@H](C)C3)oc2c(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13493420 0.87 IRAK4 (0.31) —
SCHEMBL12058157 0.87 PTPN11 (0.32) —
SCHEMBL12057987 0.80 PTPN11 (0.32) —
SCHEMBL12058492 0.79 IRAK4 (0.30) —
SCHEMBL12058431 0.78 CRHR1 (0.34) —
SCHEMBL12057756 0.77 — —
SCHEMBL12038198 0.76 IRAK4 (0.43) —
SCHEMBL12058185 0.75 VCP (0.34) —
SCHEMBL13493704 0.74 IRAK4 (0.36) —
SCHEMBL13493633 0.74 IRAK4 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110318305-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS MERCK SHARP & DOHME LLC 2011-12-29 — — US disclosed
WO-2010022121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2010-02-25 — — WO disclosed
Send feedback